Clinical Utility of Prenatal Whole Exome Sequencing (Prenatal WES)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03482141|
Recruitment Status : Recruiting
First Posted : March 29, 2018
Last Update Posted : May 10, 2019
University of California, San Francisco
Information provided by (Responsible Party):
Mary Norton, University of California, San Francisco
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Recruiting|
|Estimated Primary Completion Date :||April 30, 2021|
|Estimated Study Completion Date :||May 31, 2021|
Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, Braxton A, Beuten J, Xia F, Niu Z, Hardison M, Person R, Bekheirnia MR, Leduc MS, Kirby A, Pham P, Scull J, Wang M, Ding Y, Plon SE, Lupski JR, Beaudet AL, Gibbs RA, Eng CM. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013 Oct 17;369(16):1502-11. doi: 10.1056/NEJMoa1306555. Epub 2013 Oct 2.
Norton ME, Rink BD. Changing indications for invasive testing in an era of improved screening. Semin Perinatol. 2016 Feb;40(1):56-66. doi: 10.1053/j.semperi.2015.11.008. Epub 2015 Dec 24. Review.
Cowan RS. Aspects of the history of prenatal diagnosis. Fetal Diagn Ther. 1993 Apr;8(Suppl. 1):10-7.
Chervenak FA, McCullough LB. Ethical issues in perinatal genetics. Semin Fetal Neonatal Med. 2011 Apr;16(2):70-3. doi: 10.1016/j.siny.2010.10.004. Epub 2010 Nov 3. Review.